Siteye son 6 ay içinde eklenenler

• Feifan Liu et al. Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records
  https://link.springer.com/article/10.1007/s40264-018-0766-8


• Juergen Schmider et al. Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing
  https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.1255


• Thomas Felix et al. Current state of biologic pharmacovigilance in the European Union: improvements are needed
  https://www.tandfonline.com/doi/full/10.1080/14740338.2019.1577818


• Teresa Bellon, Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances
  https://link.springer.com/article/10.1007/s40264-019-00825-2


• Sabine Brosch et al. Establishing a Framework for the Use of Social Media in Pharmacovigilance in Europe
  https://link.springer.com/article/10.1007/s40264-019-00811-8


• Syed Ahmad, Adverse Drug Event Monitoring at the Food and Drug Administration: Your Report Can Make A Difference
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1494803/


• Niccolo Lombardi et al. Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials
  https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4740


• Peter J. Gates et al. Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC)
  https://link.springer.com/article/10.1007%2Fs40264-019-00823-4


• Gerard Socie et al. Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10?year pharmacovigilance analysis
  https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.15790


• Fabien Despas et al. Are lipid?lowering drugs associated with a risk of cataract? A pharmacovigilance study
  https://onlinelibrary.wiley.com/doi/full/10.1111/fcp.12496


• C. Lacroix et al. Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
  https://www.sciencedirect.com/science/article/pii/S0022510X19300188


• Thierry Vial et al. Adverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers
  https://www.sciencedirect.com/science/article/pii/S1297319X18303063


• Aya Ajrouche et al. Reduced risk of cancer among low?dose aspirin users: Data from French health care databases
  https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4870


• Angela S. Czaja et al. Electronic health record (EHR) based postmarketing surveillance of adverse events associated with pediatric off?label medication use: A case study of short?acting beta?2 agonists and arrhythmias
  https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4562


• Kwang Yul Jung et al. Availability of drug at convenient stores is not associated with an increased incidence of their poisoning
  https://onlinelibrary.wiley.com/doi/10.1002/pds.4760


• Shigeaki Ohno et al. Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet?s disease: a large-scale, long-term postmarketing surveillance in Japan
  https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1793-7